US Broker Ratings

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring an 81% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may find iRhythm Holdings, Inc. (NASDAQ: IRTC) an intriguing prospect, especially given its substantial potential upside of 81.46%...

Haleon plc (HLN) Stock Analysis: Exploring a 20% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, commands the attention of investors with its robust market capitalization of $44.83 billion. Specializing in consumer..

Doximity, Inc. (DOCS) Stock Analysis: Unpacking a Potential 62% Upside

For investors seeking opportunities in the healthcare sector, Doximity, Inc. (NYSE: DOCS) presents an intriguing proposition. As a leader in health information services, Doximity offers a..

RadNet, Inc. (RDNT) Stock Analysis: A 50% Potential Upside with a Strong Buy Consensus

RadNet, Inc. (NASDAQ: RDNT) is capturing investors’ attention with a compelling growth trajectory and an impressive 50.23% potential upside according to current analyst ratings. This Los..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 99% Upside in the Biotechnology Sector

Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company, is garnering investor attention within the biotechnology sector with its promising pipeline of vaccine candidates. Based in San..

Biogen Inc. (BIIB) Stock Analysis: Evaluating a 13.47% Potential Upside Amidst Market Challenges

Biogen Inc. (BIIB), a stalwart in the healthcare sector, continues to captivate investor interest with its extensive portfolio of therapies and a notable potential upside of..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 52-Week Highs and Lows for Future Growth

Investors with an eye on the healthcare sector might find Molina Healthcare Inc (NYSE: MOH) an intriguing opportunity. As a key player in the healthcare plans..

Genmab A/S (GMAB) Stock Analysis: Evaluating a 50% Potential Upside in Biotechnology

Genmab A/S (GMAB), a leader in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline and robust analyst ratings. With a..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 27% Upside Potential in Healthcare’s OTC Market

Prestige Consumer Healthcare Inc. (PBH), a key player in the over-the-counter (OTC) healthcare products market, presents a compelling investment opportunity for those looking to capitalize on..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 20% Upside Potential

Roivant Sciences Ltd. (ROIV), a biopharmaceutical company based in London, is capturing investor attention in the biotechnology sector with its promising pipeline and a notable market..

ICON plc (ICLR) Stock Analysis: Exploring a 39% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking exposure to the..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Examining the 51.55% Potential Upside

Madrigal Pharmaceuticals, Inc. (MDGL), a key player in the biotechnology sector, is making waves with its focus on developing therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). Headquartered..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Poised for 23.74% Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (JAZZ), a global player in the biotechnology sector, is capturing investor attention with a robust potential upside of 23.74% based on current analyst..

Alkermes plc (ALKS) Investor Outlook: Evaluating a 55% Upside Potential with Solid Buy Ratings

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, operates in the competitive healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market..

Legend Biotech Corporation (LEGN) Stock Analysis: A 233% Potential Upside Amidst Robust Revenue Growth

Legend Biotech Corporation (NASDAQ: LEGN) is a burgeoning player in the biotechnology sector, focusing on innovative cell therapies aimed at treating various forms of cancer. The..

UnitedHealth Group (UNH) Stock Analysis: A Look at 31% Potential Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable entity in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $250.15..

ADMA Biologics Inc (ADMA): Investor Outlook on a Biotech Firm with 79% Upside Potential

ADMA Biologics Inc (NASDAQ: ADMA) presents a compelling opportunity for investors with a keen interest in the healthcare sector, particularly within the biotechnology industry. Based in..

Insmed Incorporated (INSM) Stock Analysis: A Promising Biotech with 56.62% Potential Upside

For investors in the biotechnology sector, Insmed Incorporated (NASDAQ: INSM) represents a compelling opportunity, driven by its robust pipeline and significant potential upside of 56.62% based..

Glaukos Corporation (GKOS) Stock Analysis: A 33% Upside Potential Amid Rapid Revenue Growth

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector, has caught the attention of investors with its cutting-edge medical devices aimed at treating a..

Stevanato Group S.p.A. (STVN) Investor Outlook: Exploring a 74% Potential Upside

Stevanato Group S.p.A. (STVN), a key player in the healthcare sector, has been making waves in the medical instruments and supplies industry. Headquartered in Piombino Dese,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds